64.94
-2.56
(-3.79%)
At close: March 4 at 5:25:17 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
335,337
335,337
496,487
969,941
749,488
Investing Cash Flow
157,517
157,517
-207,677
-78,542
-207,699
Financing Cash Flow
-2,021,547
-2,021,547
-20,033
-794
6,176
End Cash Position
1,689,451
1,689,451
3,215,221
2,953,120
2,059,160
Income Tax Paid Supplemental Data
373,056
373,056
378,206
136,242
67,731
Interest Paid Supplemental Data
--
--
--
--
396
Capital Expenditure
-100,163
-100,163
-47,486
-77,833
-181,006
Repayment of Debt
-3,798
-3,798
-3,360
-2,862
-2,417
Repurchase of Capital Stock
-2,004,790
-2,004,790
--
--
--
Free Cash Flow
235,174
235,174
449,001
892,108
568,482
12/31/2021 - 12/21/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NKB2.F TG Therapeutics, Inc.
32.37
-3.20%
GNPX Genprex, Inc.
0.3350
-3.74%
SYRS Syros Pharmaceuticals, Inc.
0.0850
+3.66%
DRUG Bright Minds Biosciences Inc.
32.23
-7.70%
VRTX Vertex Pharmaceuticals Incorporated
486.22
+0.60%
REGN Regeneron Pharmaceuticals, Inc.
675.49
-1.37%
TGTX TG Therapeutics, Inc.
35.62
+3.49%